A notable proportion of patients with systemic lupus erythematosus report taking five or more medications simultaneously, ...

A new study has finally nailed down what links Epstein-Barr virus (EBV) – a pathogen that over 95 percent of adults worldwide ...

One of the world's most common viral infections could underlie virtually every case of lupus, according to a recent study ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...

UCI Health has opened a clinical trial to test an investigational cell therapy for lupus with the potential to give patients long-term remission of symptoms.

Barr virus—but new research reveals how it can hijack immune cells, sparking a chronic disease that attacks the body from ...

Pancytopenia and thrombocytopenia, but not mortality, were elevated in patients with lupus receiving immune checkpoint ...

The findings demonstrated that RAIL, a biomarker-based urine test, can effectively distinguish between active lupus kidney ...

Barr virus transforms B cells into inflammatory drivers that spark the widespread immune attacks seen in lupus.

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic ...

Despite the challenges of disease variability and high therapy costs, growing investments in targeted therapies and improved patient access initiatives are enhancing SLE management globally.